COMMUNIQUÉS West-GlobeNewswire

Deinove : Le projet « AGIR » obtient une aide de 14,6 millions d'euros du PIA
12/09/2017
Communiqué de presse 12 SEPTEMBRE 2017 Le projet « AGIR » porté par le groupe DEINOVE bénéficie d'une aide de 14,6 millions d'euros du Programme d'Investissements d'Avenir (PIA) opéré par Bpifrance pour développer de [...]
Deinove : The AGIR project carried out by the DEINOVE group is granted €14.6 m
12/09/2017
Press release 12 September 2017 The AGIR project carried out by the DEINOVE group is granted €14.6 million by the 'Investments for the Future' Program (IFP) operated by Bpifrance to develop new antibiotics. The AGIR [...]
Targovax announces start of patient recruitment in phase I/II study with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies
12/09/2017
Oslo, Norway, 12 September 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces start of patient [...]
Medtronic Announces New StealthStation(TM) Technology for Ear, Nose, and Throat Procedures
12/09/2017
New Platform to Offer Enhanced Visualization and Increased Efficiency for Surgery of the Sinuses and Skull Base DUBLIN - September 12, 2017 - Medtronic plc (NYSE: MDT) today announced the global launch of the [...]
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics
12/09/2017
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics Broad collaboration to develop a targeted Next-Generation Sequencing assay for microbial infections Workflow for native samples integrating MGI [...]
More people treated with once-weekly semaglutide achieved reductions in both glucose and weight vs. comparator treatments
12/09/2017
Lisbon, Portugal, 12 September 2017 - A post-hoc analysis of the SUSTAIN 1-5 trials demonstrated that a greater proportion of adults with type 2 diabetes achieved a clinically meaningful reduction in both HbA 1c and [...]
Fiasp® significantly improved overall blood sugar control in type 1 diabetes long-term
12/09/2017
Lisbon, Portugal, 12 September 2017 - Fiasp ® (fast-acting insulin aspart), the only approved, new-generation, ultra-fast acting 1-3 mealtime insulin, improved overall blood sugar (HbA 1c ) and post-meal sugar ( [...]
Shire Receives FDA Fast Track Designation for SHP607 for the Prevention of Chronic Lung Disease in Extremely Premature Infants
12/09/2017
Shire Receives FDA Fast Track Designation for SHP607 for the Prevention of Chronic Lung Disease in Extremely Premature Infants Cambridge, Mass. - September 12, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), the biotech [...]
NuCana Announces Positive Results of NUC-1031 (Acelarin®) in Advanced Ovarian Cancer at ESMO 2017
12/09/2017
Acelarin combination with carboplatin achieved 96% disease control rate and 39% response rate in patients with recurrent ovarian cancer EDINBURGH, United Kingdom, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NuCana plc, a [...]
AC IMMUNE COMPLETES RECRUITMENT FOR LOW-DOSE COHORT IN WORLD'S FIRST CLINICAL TRIAL FOR ANTI-ABETA VACCINE TARGETING ALZHEIMER'S DISEASE-LIKE CHARACTERISTICS IN INDIVIDUALS WITH DOWN SYNDROME
12/09/2017
AC Immune completes Recruitment for Low-Dose Cohort of Participants in World's First Clinical Trial for anti-Abeta Vaccine Targeting Alzheimer's Disease-like Characteristics in Individuals with Down Syndrome Phase 1b [...]
Saniona AB: Saniona presents Tesomet Phase 2 data at the EASD Congress
12/09/2017
PRESS RELEASE September 12, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that the promising data from its Phase 2a study with Tesomet in type 2 diabetes has been selected for two [...]
PCI Biotech: Initial clinical results from Phase I indicate that vaccination with fimaVACC enhances cellular immune responses
12/09/2017
Oslo (Norway), 12 September 2017 - PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced that the first immune [...]
Sandoz proposed biosimilar rituximab accepted for review by the FDA
12/09/2017
Rituximab is indicated to treat blood cancers and immunological diseases such as rheumatoid arthritis[1] Sandoz believes the comprehensive data package submitted to the FDA for review confirms that our biosimilar [...]
Basilea announces distribution agreement with Cardiome to commercialize antibiotic Zevtera®/Mabelio® (ceftobiprole) in Europe and Israel
12/09/2017
Basel, Switzerland, September 12, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into a distribution agreement with Cardiome Pharma Corp [...]
TiGenix strengthens US operations with senior appointments
12/09/2017
PRESS RELEASE TiGenix strengthens US operations with senior appointments - Dr. Gregory Gordon appointed as Head of Medical Department (U.S.) - Annette Valles-Sukkar appointed as Associate Director, Clinical Project [...]
TiGenix consolide ses opérations aux États- Unis suite à la nomination de cadres supérieurs
12/09/2017
COMMUNIQUÉ DE PRESSE TiGenix consolide ses opérations aux États- Unis suite à la nomination de cadres supérieurs - Dr. Gregory Gordon sera à la tête du Département Médical (États-Unis). - Annette Valles-Sukkar occupera [...]
Ossur Hf : Transactions in relation to share buyback program
11/09/2017
Announcement from Össur hf. No. 66/2017 Reykjavík, 11 September 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Sanofi: Disclosure of trading in own shares
11/09/2017
Disclosure of trading in own shares This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
Sanofi : Déclaration des transactions sur actions propres
11/09/2017
Déclaration des transactions sur actions propres This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Pages